Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Farrell

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United StatesMichael A Pfaller, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Daptomycin activity against uncommonly isolated streptococcal and other gram-positive species groupsHelio S Sader, Robert K Flamm, David J Farrell, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2015
Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13)Helio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2015
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumoniaHelio S Sader, Paul R Rhomberg, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy|July 16, 2014
Revised reference broth microdilution method for testing telavancin: effect on MIC results and correlation with other testing methodologiesDavid J Farrell, Rodrigo E Mendes, Paul R Rhomberg, et al.
Diagnostic Microbiology and Infectious Disease|June 30, 2016
In vitro spectrum of pexiganan activity; bactericidal action and resistance selection tested against pathogens with elevated MIC values to topical agentsRobert K Flamm, Paul R Rhomberg, David J Farrell, et al.
Surgical Infections|March 19, 2016
Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical CentersHelio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
Worldwide appraisal and update (2010) of telavancin activity tested against a collection of Gram-positive clinical pathogens from five continentsRodrigo E Mendes, Helio S Sader, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|October 20, 2010
Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009)Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|May 7, 2011
Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010)Helio S Sader, Gary J Moet, David J Farrell, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United StatesMichael A Pfaller, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Daptomycin activity against uncommonly isolated streptococcal and other gram-positive species groupsHelio S Sader, Robert K Flamm, David J Farrell, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2015
Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13)Helio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2015
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumoniaHelio S Sader, Paul R Rhomberg, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy|July 16, 2014
Revised reference broth microdilution method for testing telavancin: effect on MIC results and correlation with other testing methodologiesDavid J Farrell, Rodrigo E Mendes, Paul R Rhomberg, et al.
Diagnostic Microbiology and Infectious Disease|June 30, 2016
In vitro spectrum of pexiganan activity; bactericidal action and resistance selection tested against pathogens with elevated MIC values to topical agentsRobert K Flamm, Paul R Rhomberg, David J Farrell, et al.
Surgical Infections|March 19, 2016
Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical CentersHelio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
Worldwide appraisal and update (2010) of telavancin activity tested against a collection of Gram-positive clinical pathogens from five continentsRodrigo E Mendes, Helio S Sader, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|October 20, 2010
Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009)Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|May 7, 2011
Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010)Helio S Sader, Gary J Moet, David J Farrell, et al.
Pageof 18